Our verdict is Likely pathogenic. Variant got 9 ACMG points: 9P and 0B. PM1PM2PM5PP3PP5_Moderate
The NM_000548.5(TSC2):c.5056C>A(p.Gln1686Lys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Q1686P) has been classified as Pathogenic.
TSC2 (HGNC:12363): (TSC complex subunit 2) This gene is a tumor suppressor gene that encodes the growth inhibitory protein tuberin. Tuberin interacts with hamartin to form the TSC protein complex which functions in the control of cell growth. This TSC protein complex negatively regulates mammalian target of rapamycin complex 1 (mTORC1) signaling which is a major regulator of anabolic cell growth. Mutations in this gene have been associated with tuberous sclerosis and lymphangioleiomyomatosis. [provided by RefSeq, May 2022]
Verdict is Likely_pathogenic. Variant got 9 ACMG points.
PM1
In a domain Rap-GAP (size 227) in uniprot entity TSC2_HUMAN there are 284 pathogenic changes around while only 47 benign (86%) in NM_000548.5
PM2
Very rare variant in population databases, with high coverage;
PM5
Other missense variant is known to change same aminoacid residue: Variant chr16-2087930-A-C is described in Lovd as [Pathogenic].
PP3
MetaRNN computational evidence supports a deleterious effect, 0.794
PP5
Variant 16-2087929-C-A is Pathogenic according to our data. Variant chr16-2087929-C-A is described in ClinVar as [Likely_pathogenic]. Clinvar id is 1802241.Status of the report is criteria_provided_single_submitter, 1 stars.
Diagnostics Services (NGS), CSIR - Centre For Cellular And Molecular Biology
Significance: Likely pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing
The c.5056C>A variant is not present in 1000 Genomes, EVS, gnomAD and Indian Exome Database. The variant is not present in our in-house exome database. In-silico pathogenicity prediction programs like PolyPhen-2, MutationTaster2, CADD, Varsome etc. predicted this variant to be likely deleterious, however these predictions were not confirmed by any published functional studies. The variant is located in a dense mutational hotspot region of the gene and an alternative variant (c.5056C>T) in the same location was previously identified and reported to HGMD (ID: CM052387) in patients affected with Tuberous sclerosis [5]. -